Skip to main content

Table 1 Demographic and clinical data of septic shock and non-septic patients

From: High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients

  Septic shock (n = 20) Control (n = 20) P
Age [years (Q1–Q3)] 68 (59.2–76.7) 70.5 (54.2–75.5) 0.65
Male [n (%)] 17 (85) 13 (65) 0.14
BMI [kg/m2 (Q1–Q3)] 24.70 (20.2–28.6) 25 (20.2–30.5) 0.65
Dyslipidemia [n (%)] 5 (25) 3 (15) 0.69
Statin medication [n (%)] 3 (15) 0 (0) 0.23
SAPSII (Q1–Q3) 39 (29–59.5) 38 (30–51) 0.73
SOFA score (Q1–Q3) 8 (8–10) 6 (4–8) < 0.001
Mechanical ventilation [n (%)] 20 (100) 14 (70) 0.02
Need for norepinephrine [n (%)] 20 (100) 11 (55) 0.001
Norepinephrine (micg/kg/min) 0.42 (0.31–0.64) 0.12 (0.0–0.27) < 0.001
Enteral nutrition [n (%)] 12 (60) 18 (90) 0.065
Parenteral nutrition [n (%)] 5 (25) 2 (10) 0.41
Diagnosis at admission [n (%)]
 Peritonitis 10 (50)
 Pneumonia 5 (25)
 Cellulitis 2 (10)
 Arthritis 1 (5)
 Hepatic abscess 1 (5)
 Trauma 6 (30)
 Intracerebral hemorrhage 6 (30)
 Traumatic brain injury 5 (25)
 Hemorrhagic shock 2 (10)
  1. Results are expressed as medians (IQR). Between-group differences were analyzed by a Mann–Whitney test, and a Chi-square test